Prudential Financial’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58.3K | Sell |
25,700
-55,800
| -68% | -$127K | ﹤0.01% | 2333 |
|
|
2025
Q1 | $51.8K | Buy |
81,500
+17,200
| +27% | +$10.9K | ﹤0.01% | 2196 |
|
|
2024
Q4 | $66.2K | Buy |
64,300
+27,800
| +76% | +$28.6K | ﹤0.01% | 2188 |
|
|
2024
Q3 | $43.1K | Hold |
36,500
| – | – | ﹤0.01% | 2662 |
|
|
2024
Q2 | $44.5K | Buy |
36,500
+4,600
| +14% | +$5.61K | ﹤0.01% | 2625 |
|
|
2024
Q1 | $69.5K | Buy |
31,900
+15,600
| +96% | +$34K | ﹤0.01% | 2564 |
|
|
2023
Q4 | $25.3K | Hold |
16,300
| – | – | ﹤0.01% | 2604 |
|
|
2023
Q3 | $21K | Sell |
16,300
-8,400
| -34% | -$10.8K | ﹤0.01% | 2568 |
|
|
2023
Q2 | $42.5K | Sell |
24,700
-2,400
| -9% | -$4.13K | ﹤0.01% | 2551 |
|
|
2023
Q1 | $40.9K | Hold |
27,100
| – | – | ﹤0.01% | 2517 |
|
|
2022
Q4 | $43.4K | Hold |
27,100
| – | – | ﹤0.01% | 2507 |
|
|
2022
Q3 | $39K | Buy |
27,100
+7,400
| +38% | +$10.6K | ﹤0.01% | 2579 |
|
|
2022
Q2 | $36K | Buy |
+19,700
| New | +$36K | ﹤0.01% | 2590 |
|
|
2021
Q1 | – | Sell |
-83,040
| Closed | -$544K | – | 2496 |
|
|
2020
Q4 | $544K | Sell |
83,040
-72,900
| -47% | -$478K | ﹤0.01% | 2030 |
|
|
2020
Q3 | $1.04M | Sell |
155,940
-90,229
| -37% | -$600K | ﹤0.01% | 1626 |
|
|
2020
Q2 | $2.05M | Sell |
246,169
-96,842
| -28% | -$807K | ﹤0.01% | 1325 |
|
|
2020
Q1 | $2.63M | Sell |
343,011
-118,135
| -26% | -$906K | 0.01% | 1231 |
|
|
2019
Q4 | $3.83M | Buy |
461,146
+344
| +0.1% | +$2.86K | 0.01% | 1253 |
|
|
2019
Q3 | $3.4M | Buy |
460,802
+225,530
| +96% | +$1.66M | 0.01% | 1301 |
|
|
2019
Q2 | $2.64M | Buy |
235,272
+146,647
| +165% | +$1.65M | ﹤0.01% | 1463 |
|
|
2019
Q1 | $953K | Buy |
+88,625
| New | +$953K | ﹤0.01% | 1894 |
|
|
2018
Q1 | – | Sell |
-29,210
| Closed | -$617K | – | 2354 |
|
|
2017
Q4 | $617K | Buy |
+29,210
| New | +$617K | ﹤0.01% | 1962 |
|
|
2017
Q2 | – | Sell |
-28,070
| Closed | -$485K | – | 2353 |
|
|
2017
Q1 | $485K | Buy |
+28,070
| New | +$485K | ﹤0.01% | 2037 |
|